Inventurus Knowledge Solutions Limited
|
Lot Size
1 Lot = 11 Qty |
Min Investment
₹14619 |
|
Subscription
Oversubscribed |
Listing Gain
0(Points) |
IPO Details
|
Open Date
Dec 12, 2024 |
Close Date
Dec 16, 2024 |
Allotment Date
Dec 17, 2024 |
|
Allotment Date
Dec 17, 2024 |
Refund Initiation
Dec 18, 2024 |
Demat Transfer
Dec 18, 2024 |
|
Listing Date
Dec 19, 2024 |
Fresh Issue
0 |
Offer For Sale
2497.92 |
|
Issue Price
₹1265 to ₹1329 |
Face Value
₹1 |
Issue Type
Fresh Issue |
|
Total Issue Size
2497.92 CR |
QIB + NII Quota
30 + 60% |
Retail Quota
10% |
|
Listing On
NSE & BSE |
Registrar
Link Intime India Pvt Ltd |
Company Financial Rusult In Crore
| PERIOD | ASSET | REVENUE | PROFIT |
|---|---|---|---|
| 30-Sep-2024 | 2790.52 | 1294.61 | 208.58 |
| 31-Mar-2024 | 3027.52 | 1857.94 | 370.49 |
| 31-Mar-2023 | 988.31 | 1060.16 | 305.23 |
| 31-Mar-2022 | 787.52 | 784.47 | 232.97 |
About The Company
Founded in 2006, Inventurus Knowledge Solutions Limited (IKS Health) is a leading health technology company dedicated to reducing administrative burdens in healthcare. IKS Health provides end-to-end services, including clinical support, management of medical documentation, virtual medical scribing, and other administrative services, equipping doctors and healthcare organizations to make patient care their top priority.
IKS Health serves more than 800 healthcare organizations, among which are Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management, as of March 31, 2024.
13,241 employees consisting of 3,111 clinically-trained professionals are behind the excellence.
Global Operations: Its consultative sales force operates within major markets in the United States, Canada, and Australia.